SEC Form D filing
Pillar Therapeutics, Inc., 2026-05-13
An SEC Form D private-offering notice from Boston, MA, a $25,000,000 filer-stated offering target in Biotech. Filed 2026-05-13. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Pillar Therapeutics, Inc. Verified via SEC Form D
Filed 2026-05-13Filed to raise $25,000,000First money in 2026-04-14Raised so far $14,000,000HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Blitzy, Inc., 2026-05-15, $190M, Cambridge, MA
- EtiraRX, Inc., 2026-05-14, $3M, Dallas, TX
- Cue Biopharma, Inc., 2026-05-14, $30M, Boston, MA
- iSpecimen Inc., 2026-05-14, $2.5M, Woburn, MA
- Solius Labs, Inc., 2026-05-14, $17.9M, Bainbridge Island, WA
- Tycho AI Inc., 2026-05-13, $8M, Cambridge, MA
- Maneva Inc., 2026-05-13, $38.4M, Toronto, ON, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.